27.9 C
Srinagar
Thursday, June 4, 2026

Market extends losing streak for third straight session

Must read

NEW DELHI: The stock market on Friday continued its losing streak for a third consecutive session over concerns of the impact of Trump’s tariffs and a sell-off in IT shares after the TCS Q1FY26 earnings.
The Nifty 50 index fell below the 25,200 level.
At close, the Sensex was down 689.81 points, or 0.83% at 82,500.47, and the Nifty was down 205.40 points, or 0.81% at 25,149.85.
The BSE Midcap index extended the fall for a third day, falling 0.5%, while the BSE Smallcap index shed 0.7%, snapping a two-day gain.
The cumulative market capitalisation of BSE-listed firms dropped to nearly Rs 456.7 lakh crore from Rs 460 lakh crore in the previous session.
For the entire week, the Sensex and Nifty indices fell by more than a per cent each, down for a second consecutive week.
Among the sectors, almost all indices ended in the red. Some of the key ones with significant losses were Nifty IT down by 1.78%, Auto down by 1.77%, Media down by 1.60%, Oil & Gas down 1.26%, and Realty down by 1.21%.
However, those who posted some gains were Nifty Pharma, up by 0.68%, and FMCG, which was up by 0.51%.
On Nifty50, only 11 stocks managed to end higher. The top gainers were Hindustan Unilever up by 4.63%, SBI Life Insurance Company up 1.37% and Sun Pharmaceutical Industries up by 0.71%.
Further, as many as 39 stocks ended in the red in the Nifty 50 index. TCS was down 3.47%, Mahindra & Mahindra down by 2.92% and Hero MotoCorp down by 2.74%.
Shares of TCS tanked 3.5% following its Q1 earnings, with experts flagging limited clarity on growth prospects for FY26 for the IT major.
Hindustan Unilever jumped up to 5% after the company announced Priya Nair as its new MD & CEO.
Over 120 stocks on the BSE touched their 52-week highs. These included Glenmark Pharma, Asahi India, EID Parry, Ramco Cements, JK Cement, JK Lakshmi Cement, Krishna Institute of Medical Sciences, and Nippon Life India Asset Management, among others.
Agencies

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article